Literature DB >> 21862582

Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis.

Chelsea L Bueter1, Chrono K Lee, Vijay A K Rathinam, Gloria J Healy, Christopher H Taron, Charles A Specht, Stuart M Levitz.   

Abstract

Chitin is an abundant polysaccharide found in fungal cell walls, crustacean shells, and insect exoskeletons. The immunological properties of both chitin and its deacetylated derivative chitosan are of relevance because of frequent natural exposure and their use in medical applications. Depending on the preparation studied and the end point measured, these compounds have been reported to induce allergic responses, inflammatory responses, or no response at all. We prepared highly purified chitosan and chitin and examined the capacity of these glycans to stimulate murine macrophages to release the inflammasome-associated cytokine IL-1β. We found that although chitosan was a potent NLRP3 inflammasome activator, acetylation of the chitosan to chitin resulted in a near total loss of activity. The size of the chitosan particles played an important role, with small particles eliciting the greatest activity. An inverse relationship between size and stimulatory activity was demonstrated using chitosan passed through size exclusion filters as well as with chitosan-coated beads of defined size. Partial digestion of chitosan with pepsin resulted in a larger fraction of small phagocytosable particles and more potent inflammasome activity. Inhibition of phagocytosis with cytochalasin D abolished the IL-1β stimulatory activity of chitosan, offering an explanation for why the largest particles were nearly devoid of activity. Thus, the deacetylated polysaccharide chitosan potently activates the NLRP3 inflammasome in a phagocytosis-dependent manner. In contrast, chitin is relatively inert.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862582      PMCID: PMC3195641          DOI: 10.1074/jbc.M111.274936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Chitosans for gene delivery.

Authors:  G Borchard
Journal:  Adv Drug Deliv Rev       Date:  2001-11-05       Impact factor: 15.470

Review 2.  Chitosan for mucosal vaccination.

Authors:  I M van der Lubben; J C Verhoef; G Borchard; H E Junginger
Journal:  Adv Drug Deliv Rev       Date:  2001-11-05       Impact factor: 15.470

3.  Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.

Authors:  Edel A McNeela; Inderjit Jabbal-Gill; Lisbeth Illum; Mariagrazia Pizza; Rino Rappuoli; Audino Podda; David J M Lewis; Kingston H G Mills
Journal:  Vaccine       Date:  2004-02-25       Impact factor: 3.641

4.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 5.  Cell wall chemistry, morphogenesis, and taxonomy of fungi.

Authors:  S Bartnicki-Garcia
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

6.  Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice.

Authors:  Inez M van der Lubben; Gideon Kersten; Marjan M Fretz; Coen Beuvery; J Coos Verhoef; Hans E Junginger
Journal:  Vaccine       Date:  2003-03-28       Impact factor: 3.641

7.  Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages.

Authors:  Mihai G Netea; Karlijn Gijzen; Neeltje Coolen; Ineke Verschueren; Carl Figdor; Jos W M Van der Meer; Ruurd Torensma; Bart Jan Kullberg
Journal:  Microbes Infect       Date:  2004-09       Impact factor: 2.700

8.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  Endotoxin contamination in wound dressings made of natural biomaterials.

Authors:  Y Nakagawa; T Murai; Chie Hasegawa; M Hirata; T Tsuchiya; T Yagami; Y Haishima
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2003-07-15       Impact factor: 3.368

10.  Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'.

Authors:  Helen S Goodridge; Christopher N Reyes; Courtney A Becker; Tamiko R Katsumoto; Jun Ma; Andrea J Wolf; Nandita Bose; Anissa S H Chan; Andrew S Magee; Michael E Danielson; Arthur Weiss; John P Vasilakos; David M Underhill
Journal:  Nature       Date:  2011-04-28       Impact factor: 49.962

View more
  52 in total

Review 1.  Immune responses to airborne fungi and non-invasive airway diseases.

Authors:  Gaëlle Vacher; Hélène Niculita-Hirzel; Thierry Roger
Journal:  Semin Immunopathol       Date:  2014-12-13       Impact factor: 9.623

Review 2.  Beyond empiricism: informing vaccine development through innate immunity research.

Authors:  Stuart M Levitz; Douglas T Golenbock
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites.

Authors:  Lark Kyun Kim; Rimpei Morita; Yasushi Kobayashi; Stephanie C Eisenbarth; Chun Geun Lee; Jack Elias; Elizabeth E Eynon; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

4.  Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans.

Authors:  Neal Silverman; Katherine A Fitzgerald; Sandhya Ganesan; Vijay A K Rathinam; Lukas Bossaller; Kelly Army; William J Kaiser; Edward S Mocarski; Christopher P Dillon; Douglas R Green; Tanya N Mayadas; Stuart M Levitz; Amy G Hise
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

Review 5.  Micro- and nanoparticulates for DNA vaccine delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-04

6.  The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.

Authors:  Jessalyn J Baljon; Aamina Dandy; Lihong Wang-Bishop; Mohamed Wehbe; Max E Jacobson; John T Wilson
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

Review 7.  Synthetic nanovaccines for immunotherapy.

Authors:  Min Luo; Layla Z Samandi; Zhaohui Wang; Zhijian J Chen; Jinming Gao
Journal:  J Control Release       Date:  2017-03-21       Impact factor: 9.776

8.  Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs.

Authors:  Jaehyung Park; Renuka Ramanathan; Linhchi Pham; Kim A Woodrow
Journal:  Nanomedicine       Date:  2017-04-20       Impact factor: 5.307

9.  Surface structure characterization of Aspergillus fumigatus conidia mutated in the melanin synthesis pathway and their human cellular immune response.

Authors:  Jagadeesh Bayry; Audrey Beaussart; Yves F Dufrêne; Meenu Sharma; Kushagra Bansal; Olaf Kniemeyer; Vishukumar Aimanianda; Axel A Brakhage; Srini V Kaveri; Kyung J Kwon-Chung; Jean-Paul Latgé; Anne Beauvais
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

10.  The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons.

Authors:  Elizabeth C Carroll; Lei Jin; Andres Mori; Natalia Muñoz-Wolf; Ewa Oleszycka; Hannah B T Moran; Samira Mansouri; Craig P McEntee; Eimear Lambe; Else Marie Agger; Peter Andersen; Colm Cunningham; Paul Hertzog; Katherine A Fitzgerald; Andrew G Bowie; Ed C Lavelle
Journal:  Immunity       Date:  2016-03-02       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.